GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Total Liabilities

ME Therapeutics Holding (XCNQ:METX) Total Liabilities : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Total Liabilities?

ME Therapeutics Holding's Total Liabilities for the quarter that ended in Feb. 2024 was C$0.00 Mil.

ME Therapeutics Holding's quarterly Total Liabilities declined from Aug. 2023 (C$0.15 Mil) to Nov. 2023 (C$0.08 Mil) and declined from Nov. 2023 (C$0.08 Mil) to Feb. 2024 (C$0.00 Mil).

ME Therapeutics Holding's annual Total Liabilities increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$0.23 Mil) but then declined from Aug. 2022 (C$0.23 Mil) to Aug. 2023 (C$0.15 Mil).

ME Therapeutics Holding Total Liabilities Historical Data

The historical data trend for ME Therapeutics Holding's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Total Liabilities Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Total Liabilities
0.23 0.15

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Total Liabilities Get a 7-Day Free Trial 0.19 0.12 0.15 0.08 -

ME Therapeutics Holding Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ME Therapeutics Holding's Total Liabilities for the fiscal year that ended in Aug. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.148+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.15

Total Liabilities=Total Assets (A: Aug. 2023 )-Total Equity (A: Aug. 2023 )
=0.672-0.523
=0.15

ME Therapeutics Holding's Total Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=N/A

Total Liabilities=Total Assets (Q: Feb. 2024 )-Total Equity (Q: Feb. 2024 )
=1.364-1.364
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding Total Liabilities Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Total Liabilities
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines